- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05263687
Exercise Testing in Diseases and Health
Cardio Pulmonary Exercise Testing (CPET) in Diseases and Health
Cardiopulmonary exercise test (CPET) is a helpful tool for evaluation of aerobic exercise capacity and tolerance for variety of population. CPET provides a full assessment of the physiologic responses of the pulmonary, cardiovascular, muscular, and cellular oxidative systems to exercise. The test progression include a incremental stepwise (on treadmill) or ramp control protocol (on bike ergometer ) to exhaustion. Measurement of respiratory gas exchange i.e. oxygen uptake, carbon dioxide, minute ventilation, other variables while monitoring ECG, blood pressure, pulse oximetry and exertion perceived (Borg Scale) during an incremental test .
Aim: To compere exercise responses for maximal exercise testing with different population.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Each participants will conducted an exercise test on treadmill using Modified Bruce Protocol) or cycle ergometer. Quark CPET metabolic cart (Cosmed, Rome, Italy) will be use to collect and analysis gas exchange. 10 minute after the graded exercise test Supra maximal exercise test (SMT) will be done for 2 minutes one stage (treadmill protocol) or 10% at cycle protocol higher than highest load achieved in the incremental test.
all outcome measurement will be collected. Exercise tolerance and responses will be assess using the data of : pulmonary gas exchange; cardiovascular performance, and skeletal muscle metabolism.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gur Mainzer, MD
- Phone Number: +972543078940
- Email: GMainzer@poria.health.gov.il
Study Contact Backup
- Name: Einat Kodesh, PhD
- Phone Number: +972523489854
- Email: Ekodesh@poria.health.gov.il
Study Locations
-
-
The Lower Galilee
-
Teverya, The Lower Galilee, Israel, 15208
- Recruiting
- The Baruch Padeh Medical Center, Poriya
-
Contact:
- Odelia Katz
- Email: okatz@poria.health.gov.il
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
*Patient who invited to the clinic to do incremental maximal exercise test or healthy *Participants with no known significant health problems.
Exclusion Criteria:
- Acute fever
- Acute myocardial infarction within 2 to 3 days.
- Unstable angina not previously stabilized by medical therapy.
- Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise.
- Symptomatic severe aortic stenosis.
- Uncontrolled symptomatic heart failure.
- Inability to perform exercise Orthopedic impairment severely compromising exercise performance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Exercise Test
maximal and anaerobic threshold cardiopulmonary parameters
|
Each participants will conduct a spirometry test and exercise test on treadmill (using Modified Bruce Protocol) or cycle ergometer.
Quark CPET metabolic cart (Cosmed, Rome, Italy) will be used to collect and analysis gas exchange, ECG, gas volume in addition rating of perceived exertion will be asked.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal Oxygen consumption
Time Frame: through study completion, an average of 1 year
|
the maximum amount of oxygen that an individual can utilize during intense or maximal exercise.
|
through study completion, an average of 1 year
|
|
Maximal Heart rate
Time Frame: through study completion, an average of 1 year
|
the maximum heart rate achieved during intense or maximal exercise.
|
through study completion, an average of 1 year
|
|
Maximal Blood pressure
Time Frame: through study completion, an average of 1 year
|
the blood pressure in the end of intense or maximal exercise.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ventilation Anaerobic Threshold
Time Frame: through study completion, an average of 1 year
|
Ventilatory Threshold (VT) describes the inflection point for ventilation during an incremental exercise test.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gur Mainzer, MD, The Baruch Padeh Medical Center, Poriya
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0033-17-POR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.